Navigation Links
Reportlinker Adds France Pharmaceutical Market Overview - Austerity measures will impact pharmaceutical market growth
Date:1/11/2011

NEW YORK, Jan. 11, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

France Pharmaceutical Market Overview – Austerity measures will impact pharmaceutical market growth

http://www.reportlinker.com/p0360215/France-Pharmaceutical-Market-Overview-–--Austerity-measures-will-impact-pharmaceutical-market-growth.html

Introduction

The prescription pharma market in France was valued at $38.8bn in sales in 2009, having by 3.1% (CAGR; 2005–09). Key growth drivers include growing use of chronic high-value innovative treatments driven by an aging population, high public healthcare expenditure as proportion of total healthcare expenditure, physician preference for prescribing branded drugs as well as high patient brand loyalty.

Features and benefits

* Overview of socioeconomic and demographic trends, healthcare system, regulation, pricing and reimbursement and intellectual property in France

* Assesses the size of the French pharmaceutical market by prescribing setting, therapy area, leading brands and by leading companies

* Examines the French generics and biosimilars landscape in terms of regulatory issues, level of penetration, key players and degree of brand erosion

* Quantifies the R&D and manufacturing infrastructure for the leading pharmaceutical companies, including key metrics and domestic M&A analysis

Highlights

Despite having a higher birth rate than most European countries, with its ageing population France is encountering difficulties in handling its health account deficit, a situation made worse by the economic downturn. Hence France has turned towards social system reforms and austerity measures. Despite having a favourable market for innovative and expensive drugs a range of cost-cutting measures such as pricing and reimbursement cuts will have a negative impact on the French pharmaceutical market. Once considered the immature generics market, France has considerably increased its generics uptake although there is still a significant scope for improvement. Physicians' resistance to generics use remains the greatest obstacle with adequate physicians' financial incentives necessary in the future.

Your key questions answered

* Evaluate the evolving regulatory landscape and the impact of pricing and reimbursement controls on market access in France

* Quantify the size and growth of the prescription pharmaceutical market in France, analyzing key therapy areas, brands and companies

* Assess drivers and resistors of generic and biosimilars uptake in France

To order this report:

: France Pharmaceutical Market Overview – Austerity measures will impact pharmaceutical market growth

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Innovative Drug Discovery in Emerging Markets
2. Reportlinker Adds Chugai Pharmaceutical Co., Ltd: PharmaVitae Profile
3. Reportlinker Adds Cosmetic Surgery Products
4. Reportlinker Adds Regenerative Medicine Markets
5. Reportlinker Adds Womens Health Diagnostic Testing
6. Reportlinker Adds 2010-2015 In-depth Research Report on China Sodium Fluoride Industry
7. Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012
8. Reportlinker Adds The Outlook for Pharmaceuticals in Central Asia
9. Reportlinker Adds The Outlook for Pharmaceuticals in Western Europe
10. Reportlinker Adds Mammography World Markets
11. Reportlinker Adds Molecular Diagnostics in Cancer Testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... 2016 Research and Markets has announced the addition ... report to their offering. ... The report also analyses the market by the following Technology Types: ... for the US, Canada , Japan ... Latin America , and Rest of World. ...
(Date:12/9/2016)... 9, 2016 aTyr Pharma, Inc. (Nasdaq: LIFE ... Physiocrine-based therapeutics to address severe, rare diseases, today announced that senior ... Prescriptions for Success Healthcare Conference at the InterContinental Barclay Hotel in ... 2016, at 4:20 p.m. ET. About aTyr Pharma ... aTyr Pharma ...
(Date:12/9/2016)... 2016  Forge Therapeutics, Inc. today announced a ... EVT, TecDAX, ISIN: DE0005664809) to advance its novel ... of bacterial infections including those caused by drug ... attractive antibacterial target for more than the past ... starting points has hampered its progress. Forge has ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... Flottman Company ... outserts. As a means of expanding capabilities Flottman has added a G&K ... individually code professional inserts (PIs) and patient package inserts (PPIs) that will marry ...
(Date:12/9/2016)... Hills, CA (PRWEB) , ... December 09, 2016 ... ... for young adults, celebrated its 10th anniversary with the grand opening of the ... California. The successful event spanned two days, December 2-3, and was attended by ...
(Date:12/9/2016)... Fort Lee, NJ (PRWEB) , ... December 09, ... ... the 2016 Founders Ball at The Pierre Hotel in New York, NY, on ... 700 friends, benefactors, dignitaries and physicians attended the annual event, which raised over ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Pennsylvania Athletic ... (PCN) during the summer of 2016. The program was made possible by a ... States Department of Health and Human Services Administration. The broadcast, Use Your ...
(Date:12/8/2016)... ... December 08, 2016 , ... After ... officially opened registration today for its 33rd Annual Issues & Research Conference, ... , The theme of the conference is “Persistent Challenges and New Opportunities: Using ...
Breaking Medicine News(10 mins):